Page last updated: 2024-08-23

pirfenidone and Liver Cirrhosis, Alcoholic

pirfenidone has been researched along with Liver Cirrhosis, Alcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez-Rodríguez, A; Arellano-Olivera, I; Armendáriz-Borunda, J; Bautista, CA; Bueno-Topete, M; García-Rocha, S; Godoy, J; González-García, I; Islas-Carbajal, MC; Lucano, S; Medina-Preciado, D; Muñoz-Valle, JF; Oregón-Romero, E; Rincón, AR; Salazar, A; Troyo-SanRoman, R; Vázquez-Del Mercado, M	1

Other Studies

1 other study(ies) available for pirfenidone and Liver Cirrhosis, Alcoholic

Article	Year
Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2008, Volume: 56, Issue:7 Topics: Adult; Aged; Angiotensinogen; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; DNA Primers; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Mexico; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Pyridones; Transforming Growth Factor beta	2008

Article

Year

Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2008, Volume: 56, Issue:7

Topics: Adult; Aged; Angiotensinogen; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; DNA Primers; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Mexico; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Pyridones; Transforming Growth Factor beta

2008